NRX Pharmaceuticals Inc

NASDAQ:NRXP

3.38

+0.06 (+1.81%)

4:44:57 PM EDT: $3.27 -0.11 (-3.25%)

Market Cap (Intraday)	67.11M
Current PE	N/A
Forward PE	N/A
2yr Forward PE	4.83

See more stats

Estimates Current Quarter

Revenue	$1 Million
Adjusted EPS	-$0.20

See more estimates

10-Day MA	N/A
50-Day MA	N/A
200-Day MA	N/A

See more pivots

NRX Pharmaceuticals Inc Stock, NASDAQ:NRXP

1201 Orange Street, Suite 600, Wilmington, Delaware 19801

United States of America

Phone: +1.484.254.6134

Number of Employees:

http://www.nrxpharma.com

Description

NRX Pharmaceuticals, Inc. is a clinical-stage small molecule pharmaceutical company. It engages in developing of novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. The company was founded on September 18, 2017 and is headquartered in Wilmington, DE.